Press Releases

AMERICAN FORK, Utah, Aug. 22, 2019 /PRNewswire/ -- Due to its exponential growth rate and exceptional client satisfaction, eAssist Dental Solutions (https://dentalbilling.com/

BERWYN, Pa., Aug. 22, 2019 /PRNewswire/ -- ATIXA has, at times, issued position statements when it sees an unhealthy direction in the field in the hope that its position can offer some level of correction. ATIXA issues this 

LONDON, Aug., 22, 2019 /PRNewswire/ -- Clinithink has been shortlisted for the Connecting Services and Information Award at this year's HSJ Awards for their joint submission with Newcastle Upon Tyne Hospitals NHS Foundation Trust. The submission was based on a partnership that saw Clinithink's CLiX ENRICH solution successfully used by the Trust's clinical resea

BEAVERTON, Ore., Aug. 22, 2019 /PRNewswire/ -- The following statement is being issued by The Association for the Treatment of Sexual Abusers:The country has understandably been shocked and appalled by the heinous actions, both confirmed and alleged, involving the sexual abuse and trafficking of children perpetrated by Jeffrey Epstein

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate's top priority is seeing to it that a Navy Veteran with mesothelioma rece

BOSTON, Aug. 22, 2019 /PRNewswire/ -- meQuilibrium research found that burnout is a common problem in the workplace, with 25% of survey respondents at high risk for

LOS ALAMOS, N.M., Aug. 22, 2019 /PRNewswire/ -- Knoze Jr. (https://allerpops.com/) is advising their customers to that using AllerPops a couple of times before the allergy seaso

SOUTH SAN FRANCISCO, Calif., Aug. 22, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Company will participate in the following conferences in September.Citi's 14th Annual Biotech Conference on Wednesday, September 4, 2019, in

STERLING, Va., Aug. 22, 2019 /PRNewswire/ --Aperiomics, the fast-growing biotech company combining the latest advancements in science, technology, and medicine to change the way healthcare providers id

LAKEWAY, Texas, Aug. 22, 2019 /PRNewswire/ -- JFL Capital Management, LLC, together with its affiliates and the other participants in its solicitation, the largest stockholder of Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") (NASDAQ: MACK), with ownership of approximately 18.7% of the Company's outstanding shares, announced today that it has issued a le